Skip to main content

NIH and National Foundation Expenditures For Sickle Cell Disease and Cystic Fibrosis Are Associated With Pubmed Publications and FDA Approvals

Publication ,  Conference
Strouse, JJ; Lobner, K; Lanzkron, S; Haywood, C
Published in: BLOOD
November 15, 2013

Duke Scholars

Published In

BLOOD

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 15, 2013

Volume

122

Issue

21

Location

New Orleans, LA

Publisher

AMER SOC HEMATOLOGY

Conference Name

55th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Strouse, J. J., Lobner, K., Lanzkron, S., & Haywood, C. (2013). NIH and National Foundation Expenditures For Sickle Cell Disease and Cystic Fibrosis Are Associated With Pubmed Publications and FDA Approvals. In BLOOD (Vol. 122). New Orleans, LA: AMER SOC HEMATOLOGY.
Strouse, John J., Katie Lobner, Sophie Lanzkron, and Carlton Haywood. “NIH and National Foundation Expenditures For Sickle Cell Disease and Cystic Fibrosis Are Associated With Pubmed Publications and FDA Approvals.” In BLOOD, Vol. 122. AMER SOC HEMATOLOGY, 2013.

Published In

BLOOD

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 15, 2013

Volume

122

Issue

21

Location

New Orleans, LA

Publisher

AMER SOC HEMATOLOGY

Conference Name

55th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology